Expertise in
16
conditions

Dr. Collin D. Driscoll

Radiation Oncology
Gundersen Clinic LTD.
505 Gopher Dr, 
Tomah, WI 
Accepting New Patients
Offers Telehealth
Expertise in
16
conditions
Gundersen Clinic LTD.
505 Gopher Dr, 
Tomah, WI 

Overview

Collin Driscoll is a Radiation Oncologist practicing medicine in Tomah, Wisconsin.

Dr. Driscoll is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Primitive Neuroectodermal Tumor (PNET), and Posterior Fossa Tumor.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 31 clinical trials. Dr. Driscoll is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in WI

Hospital Affiliations

Gundersen St Josephs Hospital And Clinics
Gundersen Lutheran Medical Center
Tomah Memorial Hospital
Gundersen Tri-County Hospital & Clinics

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Quartz
  • HMO
  • POS
  • PPO
Quartz Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Gundersen Clinic LTD.
505 Gopher Dr, Tomah, WI 54660
Other Locations
Gundersen Pharmacy
1836 South Ave, La Crosse, WI 54601

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

31 Clinical Trials

RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Enrollment Status: Suspended
Publish Date: September 04, 2026
Intervention Type: Procedure, Radiation, Drug
Study Drug: Atezolizumab
Study Phase: Phase 2/Phase 3
Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Enrollment Status: Suspended
Publish Date: September 01, 2026
Intervention Type: Procedure, Drug, Other, Radiation, Biological
Study Drugs: Atezolizumab, Cetuximab, Cisplatin, Docetaxel
Study Phase: Phase 2/Phase 3
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Cisplatin, Fluorouracil, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Enrollment Status: Active_not_recruiting
Publish Date: August 27, 2026
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Atezolizumab, Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 3
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Enrollment Status: Completed
Publish Date: August 27, 2026
Intervention Type: Other, Biological, Radiation
Study Drugs: Cetuximab, Durvalumab
Study Phase: Phase 2/Phase 3
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS for Resected Metastatic Brain Disease
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS for Resected Metastatic Brain Disease
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2026
Intervention Type: Radiation, Procedure, Other
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire in Women With Breast or Gynecologic Cancer
Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire in Women With Breast or Gynecologic Cancer
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Drug
Study Drug: Bupropion Hydrochloride
Study Phase: Phase 2
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Radiation, Procedure
Study Phase: Phase 2/Phase 3
View 9 Less Clinical Trials

1 Total Publications

Institutional review of compliance with NCCN guidelines for breast cancer: lessons learned from real-time multidimensional synoptic reporting.
Institutional review of compliance with NCCN guidelines for breast cancer: lessons learned from real-time multidimensional synoptic reporting.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 19, 2015
Similar Doctors
Expertise in
14
conditions
Dr. Douglas G. Gold
Radiation Oncology
Expertise in
14
conditions
Dr. Douglas G. Gold
Radiation Oncology
Referral may be required

Gundersen Clinic LTD.

505 Gopher Dr, 
Tomah, WI 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Douglas Gold is a Radiation Oncologist practicing medicine in Tomah, Wisconsin. Dr. Gold is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Oligodendroglioma, Embryonal Tumor with Multilayered Rosettes, and Gliosarcoma. Dr. Gold is currently accepting new patients.

Expertise in
19
conditions
Dr. Patrick D. Conway
Radiation Oncology
Expertise in
19
conditions
Dr. Patrick D. Conway
Radiation Oncology
Referral may be required

Mayo Clinic Health System In Lacrosse

700 West Ave S, 
La Crosse, WI 
 (37.9 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Patrick Conway is a Radiation Oncologist practicing medicine in La Crosse, Wisconsin. Dr. Conway is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, and Endometrial Cancer. Dr. Conway is currently accepting new patients.

Expertise in
20
conditions
Dr. Abigail L. Stockham
Radiation Oncology
Expertise in
20
conditions
Dr. Abigail L. Stockham
Radiation Oncology
Referral may be required

Mayo Clinic Health System-Southwest Wisconsin Region Inc.

800 West Ave S, 
La Crosse, WI 
 (37.8 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Abigail Stockham is a Radiation Oncologist practicing medicine in La Crosse, Wisconsin. Dr. Stockham is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, and Adult Soft Tissue Sarcoma. Dr. Stockham is currently accepting new patients.

Frequently Asked Questions about Dr. Collin D. Driscoll

How do I make an appointment with Dr. Collin D. Driscoll?

You can book an appointment with Dr. Collin D. Driscoll by calling their office at 608-782-7300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Collin D. Driscoll a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Collin D. Driscoll is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Collin D. Driscoll specialize in?

While Dr. Collin D. Driscoll is a Radiation Oncology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Primitive Neuroectodermal Tumor (PNET). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Collin D. Driscoll participate in research or clinical trials?

Yes. Dr. Collin D. Driscoll has published 1 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Collin D. Driscoll's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Collin D. Driscoll accept my insurance?

Dr. Collin D. Driscoll accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 608-782-7300 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Driscoll's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 18 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile